EyeGene Market Cap

EyeGene has a market cap or net worth of 52.76 billion as of December 5, 2025. Its market cap has decreased by -35.26% in one year.

Market Cap

52.76B

Enterprise Value

29.27B

Revenue

4.10B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,952.00

Market Cap Chart

Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 52.76B, a decrease of -59.72%. That is a compound annual growth rate of -8.64%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	52.76B	-23.75%
Dec 30, 2024	69.20B	-24.46%
Dec 28, 2023	91.61B	-15.21%
Dec 29, 2022	108.04B	-73.58%
Dec 30, 2021	408.92B	175.32%
Dec 30, 2020	148.53B	11.93%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	688.99T
SK hynix	374.23T
LG Energy Solution	95.94T
Samsung Biologics	77.77T
Hyundai Motor Company	61.60T
Doosan Enerbility	50.72T
HD Hyundai Heavy Industries	46.78T
KB Financial Group	46.53T

Market Cap Rankings